These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 239474

  • 21. Human lymphotoxin: purification and some properties.
    Granger GA, Laserna EC, Kolb WP, Chapman F.
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):27-30. PubMed ID: 4509662
    [Abstract] [Full Text] [Related]

  • 22. Human lymphotoxin obtained from established lymphoid lines: purification characteristics and inhibition by anti-immunoglobulin.
    Amino N, Linn ES, Pysher TJ, Mier R, Moore GE, DeGroot LJ.
    J Immunol; 1974 Oct; 113(4):1334-45. PubMed ID: 4547222
    [No Abstract] [Full Text] [Related]

  • 23. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE.
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [Abstract] [Full Text] [Related]

  • 24. The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro.
    Granger GA, Yamamoto RS, Fair DS, Hiserodt JC.
    Cell Immunol; 1978 Jul; 38(2):388-402. PubMed ID: 307989
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Recombinant human lymphotoxin: synthesis in Escherichia coli cells, purification, and certain properties].
    Denisov AA, Torskiĭ SP, Nikolaeva OG, Volozhantseva IIa.
    Biokhimiia; 1995 Sep; 60(9):1403-10. PubMed ID: 8562649
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Purification to electrophoretic homogeneity of human alpha lymphotoxin from a cloned continuous lymphoblastoid cell line IR 3.4.
    Johnson DL, Yamamoto RS, Plunkett JM, Masunaka IK, Granger GA.
    Mol Immunol; 1983 Nov; 20(11):1241-4. PubMed ID: 6606757
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. No direct activation of fluid phase C3 by lymphokines.
    Kirchhoff W, Sorg C.
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):431-7. PubMed ID: 842071
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Primary structure of C-1-a 1 --a cyanogen bromide fragment of heavy chain from inbred guinea pig immunoglobulin G(2), which contains a markedly variable segment.
    Birshtein BK, Cebra JJ.
    Biochemistry; 1971 Dec 21; 10(26):4930-7. PubMed ID: 5134538
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of lectin-induced cellular cytotoxicity mediated by mouse spleen cells and the role of lymphotoxin.
    Sawada J, Osawa T.
    Immunology; 1980 Nov 21; 41(3):525-34. PubMed ID: 6970163
    [Abstract] [Full Text] [Related]

  • 40. Molecular and biological characterization of anticarcinogenic and tumor cell growth-inhibitory activities of Syrian hamster lymphotoxin.
    Ransom JH, Evans CH.
    Cancer Res; 1983 Nov 21; 43(11):5222-7. PubMed ID: 6604574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.